About the Company
We do not have any company description for Zura Bio Ltd at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Zura Bio Ltd
Zura Bio Ltd (94E.SG) - Yahoo Finance
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer HENDERSON, Nev, March 28, 2024--Zura Bio Limited (Nasdaq: ZURA) ("Zura ...
Ladenburg Thalmann Initiates Coverage of Zura Bio Ltd - (ZURA ... - Nasdaq
Analyst Price Forecast Suggests 174.56% Upside As of October 5, 2023, the average one-year price target for Zura Bio Ltd - is 18.62. The forecasts range from a low of 14.14 to a high of $23.10.
Zura Bio Ltd director acquires $3.7m in company shares
In a recent transaction, Zura Bio Ltd's director, Someit Sidhu, has made a significant investment in the company by acquiring shares valued at approximately $3.7 million.
Zura Bio Ltd (ZURA) Reports Full Year 2023 Financial Results Amidst ...
Zura Bio Ltd (NASDAQ:ZURA) reported a net loss of $60.4 million for the year ended December 31, 2023, which is a significant increase from the $25.7 million net loss in the previous year.
Zura Bio Ltd (94E.SG) latest press releases and corporate news ...
HENDERSON, Nev., November 25, 2024--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and ...
Raymond James Maintains Zura Bio Ltd - (ZURA) Strong Buy ... - Nasdaq
Analyst Price Forecast Suggests 152.77% Upside As of August 2, 2023, the average one-year price target for Zura Bio Ltd - is 17.34. The forecasts range from a low of 14.14 to a high of $21.00.
Zura Bio Ltd (94E.SG) Latest Stock News & Headlines - Yahoo Finance
HENDERSON, Nev., February 24, 2025--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and ...
Zura Bio Ltd (94E.SG) - Yahoo Finance
HENDERSON, Nev., February 24, 2025--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and ...
Zura Bio Ltd director acquires $3.7m in company shares
InvestingPro Insights Following the significant share purchase by Zura Bio Ltd's director, Someit Sidhu, investors may find additional context in recent data and analysis from InvestingPro. The ...
Zura Bio Ltd (94E.SG) - Yahoo Finance
Get the latest Zura Bio Ltd (94E.SG) stock news and headlines to help you in your trading and investing decisions.
Zura Bio Ltd (94E.SG) - Yahoo Finance
HENDERSON, Nev., June 03, 2024--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, ...
Similar Companies
Loading the latest forecasts...